MIDAZOLAM HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Midazolam Hydrochloride patents expire, and what generic alternatives are available?
Midazolam Hydrochloride is a drug marketed by Apothecon, Baxter Hlthcare Corp, Bedford, Ben Venue, Epic Pharma Llc, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Hospira Inc, Igi Labs Inc, Intl Medicated, Intl Medication, Micro Labs, Pai Holdings, Rising, Akorn, Padagis Us, Pharm Assoc, Sun Pharm Inds Ltd, Rafa Labs Ltd, and Steriscience. and is included in thirty-six NDAs.
The generic ingredient in MIDAZOLAM HYDROCHLORIDE is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midazolam Hydrochloride
A generic version of MIDAZOLAM HYDROCHLORIDE was approved as midazolam hydrochloride by FRESENIUS KABI USA on June 20th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIDAZOLAM HYDROCHLORIDE?
- What are the global sales for MIDAZOLAM HYDROCHLORIDE?
- What is Average Wholesale Price for MIDAZOLAM HYDROCHLORIDE?
Summary for MIDAZOLAM HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 22 |
NDAs: | 36 |
Finished Product Suppliers / Packagers: | 21 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Clinical Trials: | 1,466 |
Patent Applications: | 1,069 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in MIDAZOLAM HYDROCHLORIDE? | MIDAZOLAM HYDROCHLORIDE excipients list |
DailyMed Link: | MIDAZOLAM HYDROCHLORIDE at DailyMed |
![MIDAZOLAM HYDROCHLORIDE drug patent expirations Drug patent expirations by year for MIDAZOLAM HYDROCHLORIDE](/p/graph/s/t/MIDAZOLAM_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for MIDAZOLAM HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Exeter | Phase 1/Phase 2 |
University Hospital of North Norway | Phase 1/Phase 2 |
LINK Medical Research AB | Phase 1 |
Pharmacology for MIDAZOLAM HYDROCHLORIDE
Drug Class | Benzodiazepine |